Project Grant K01CA304478
Award Date 8/6/25
Completion Date 7/31/29
Dollars Obligated $198K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Chapel Hill, NC 27599, USA
Similar Awards
- The National Cancer Institute (NCI), part of the U.S. Department of Health and Human Services, awarded a $1,338,648 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to the University of Pittsburgh. The grant will fund a "Hybrid Type I Cluster Randomized Effectiveness-Implementation Trial of CARES" to address clinically significant levels of depression, pain, and fatigue experienced by over 18 million Americans living with cancer. The project aims to...
- This Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower program) provides $192,489.00 to the University of Alabama at Birmingham to evaluate the implementation and impact of standard-of-care delivered oncology financial navigation. The oncology financial navigation intervention aims to help cancer patients prepare for out-of-pocket treatment costs, optimize health insurance, and access financial resources to combat cancer-related financial hardship....
- The National Cancer Institute (NCI) awarded a $191,490 Project Grant under the Cancer Research Manpower (CFDA 93.398) program to the University of Kansas Medical Center Research Institute, Inc. (KUMCRI) for the project "Implementing Pathways to Identify and Address Employment Concerns Among People with Cancer Across Diverse Clinical Settings." The overall objective is to identify and refer cancer patients with employment concerns to existing support resources through implementation and...
- The University of North Carolina at Chapel Hill received a $159,540 Project Grant award from the National Cancer Institute under the Cancer Research Manpower (CFDA 93.398) federal grant program. The grant supports a research project titled "Mechanistic Examination and Inhibitor Targeting of Nutrient Scavenging for the Treatment of Pancreatic Cancer." The project aims to investigate the role of macropinocytosis and autophagy, two metabolic processes that cancer cells use to obtain...
- The National Cancer Institute awarded a $150,784 Project Grant under the Cancer Biology Research federal grant program (CFDA 93.396) to the University of North Carolina at Charlotte (UNC Charlotte). The award period runs from September 1, 2025 to August 31, 2027. The project aims to investigate the role of post-translational modifications on the HSP70 chaperone protein and its impact on regulating the cell cycle protein cyclin D1, which is often dysregulated in cancer. Specifically, the research...
- This federal Project Grant award, totaling $696,140, was provided by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program. The grant aims to test a digital psychoeducation-activation tool and implementation strategy, called ICAN DEPCARE, to improve uptake of evidence-based depression treatment among cancer patients. The project, led by The Trustees of Columbia University in the City of New York, will conduct a clinic-level cluster randomized...
- The National Cancer Institute (NCI) awarded a $361,695 Project Grant under the Cancer Treatment Research program (CFDA 93.395) to the University of Oklahoma Health Sciences Center (OUHSC) for the period of September 1, 2025 to August 31, 2029. The grant aims to: 1) Leverage novel mHealth applications to boost enrollment in NCI-sponsored clinical trials, 2) Promote representative clinical trial enrollment from the local catchment area population, 3) Expand Veteran access to NCI trials, and 4)...
- The National Cancer Institute awarded a 5-year, $667,379 Project Grant under the Cancer Treatment Research program (CFDA 93.395) to the University of California, Irvine (UCI) on February 1, 2025. The grant supports research to decode the role of polyadenylation, a critical mRNA processing step, in health and disease. Key activities include computational modeling to predict the impact of genetic variants on mRNA stability and processing, as well as high-throughput experiments to quantify how...
- The National Cancer Institute (NCI) awarded a $328,822 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to Implenomics Llcs, a minority-owned, women-owned small business located in Marblehead, Massachusetts. The grant, effective September 20, 2024 through August 31, 2026, will fund the development and pilot testing of the Integrated Cancer Awareness Network (ICAN), an innovative mHealth platform. ICAN will provide cancer risk, symptom, and screening education to...
- The National Cancer Institute (CFDA 93.398 Cancer Research Manpower) awarded a $314,775 Project Grant to the University of Alabama at Birmingham to test the INCITE (Increasing Caregiver Support Implementation through Training and Education) program. The INCITE program is designed to train cancer centers and their staff on identifying, implementing, evaluating, and sustaining evidence-based cancer caregiver support programs. The goal is to address the lack of formal support services for the 3.3...